NUCLEIC ACID CONSTRUCTS USEFUL FOR GLUCOSE REGULATED PRODUCTION OF HUMAN INSULIN IN SOMATIC CELL LINES

Details for Australian Patent Application No. 2002315010 (hide)

Owner BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

Inventors BARTON, Randall, Wilber; TATAKE, Revati, J.; SCHNEIDERMAN, Richard

Pub. Number AU-A-2002315010

PCT Number PCT/US02/18291

PCT Pub. Number WO2002/101074

Priority 60/296,936 08.06.01 US; 60/299,334 19.06.01 US

Filing date 10 June 2002

Wipo publication date 23 December 2002

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 60/296,936 08.06.01 US; 60/299,334 19.06.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-A-2002315010

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002315011-Method and apparatus for treadmill with frameless treadbase

2002315009-Thioether substituted imidazoquinolines